COMBI-KEL 40, injekcinė suspensija
COMBI-KEL 40, injekcinė suspensija
Authorised
- Dihydrostreptomycin
- Benzylpenicillin procaine
Product identification
Medicine name:
COMBI-KEL 40, injekcinė suspensija
Active substance:
- Dihydrostreptomycin
- Benzylpenicillin procaine
Target species:
-
Dog
-
Cat
-
Cattle
-
Sheep
-
Horse
-
Pig
Route of administration:
-
Subcutaneous use
-
Intraperitoneal use
-
Intramuscular use
Product details
Active substance and strength:
-
Dihydrostreptomycin200.00milligram(s)1.00millilitre(s)
-
Benzylpenicillin procaine200.00milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
- Dog
- Cat
-
Intraperitoneal use
- Cattle
-
Meat112day
-
Milk4day4 days or 8 milkings.
-
- Sheep
-
Milkno withdrawal periodNot authorized for use in sheep, whose milk is meant for human consumption.
-
-
Intramuscular use
- Horse
-
Meat and offalno withdrawal periodNot authorized for use in horses, who are for human consumption.
-
- Cattle
-
Meat112day
-
Milk4day4 days or 8 milkings.
-
- Pig
-
Meat116day
-
- Sheep
-
Milkno withdrawal periodNot authorized for use in sheep, whose milk is meant for human consumption.
-
- Dog
- Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01RA01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Lithuania
Package description:
- Available only in Lithuanian
- Available only in Lithuanian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
- Kela Kempisch Laboratorium Kela Laboratoria
Marketing authorisation date:
Manufacturing sites for batch release:
- Kela - Kempisch Laboratorium - Kela Laboratoria
Responsible authority:
- State Food And Veterinary Service
Authorisation number:
- LT/2/97/0550/001-002
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Lithuanian (PDF)
Published on: 21/03/2024
How useful was this page?: